scholarly article | Q13442814 |
P2093 | author name string | Peter F Weller | |
Lisa A Spencer | |||
Josiane S Neves | |||
Sandra A C Perez | |||
Amy L Radke | |||
Casey L Kirchhoffer | |||
Craig T Szela | |||
P2860 | cites work | IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells | Q72412467 |
EliCell: a gel-phase dual antibody capture and detection assay to measure cytokine release from eosinophils | Q73081440 | ||
Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection | Q73690836 | ||
Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function | Q74481539 | ||
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system | Q80102518 | ||
Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha | Q81317318 | ||
Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment | Q24301442 | ||
Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 | Q24597517 | ||
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes | Q24671876 | ||
Human eosinophils express and release IL-13 following CD28-dependent activation | Q28207371 | ||
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. | Q30489042 | ||
Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon gamma | Q32084242 | ||
Eosinophil cytokines | Q33889418 | ||
Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. | Q34480114 | ||
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells | Q34556912 | ||
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells | Q36362214 | ||
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma | Q36369722 | ||
Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion | Q36371243 | ||
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells | Q36376543 | ||
Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite | Q36399604 | ||
Differential secretion of cytokines | Q36498889 | ||
Lymph node trafficking and antigen presentation by endobronchial eosinophils | Q37176309 | ||
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. | Q37274179 | ||
Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells | Q37327205 | ||
Human eosinophils produce biologically active IL-12: implications for control of T cell responses. | Q41029744 | ||
Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product | Q41673322 | ||
Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein | Q41702000 | ||
Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis | Q41840474 | ||
Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulatio | Q42755866 | ||
Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease | Q42876606 | ||
Eokines: synthesis, storage and release from human eosinophils | Q44014774 | ||
Helper T cells regulate type-2 innate immunity in vivo | Q44154038 | ||
Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production | Q46528021 | ||
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. | Q55045567 | ||
Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome | Q70503913 | ||
Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development | Q70916529 | ||
Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes | Q71029723 | ||
P433 | issue | 1 | |
P921 | main subject | human eosinophil | Q101405048 |
P304 | page(s) | 117-123 | |
P577 | publication date | 2008-10-07 | |
P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
P1476 | title | Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially | |
P478 | volume | 85 |
Q38739017 | 2-(4-{2-[(phenylthio)acetyl]carbonohydrazonoyl}phenoxy)acetamide as a new lead compound for management of allergic rhinitis |
Q97550316 | A new dawn for eosinophils in the tumour microenvironment |
Q55059420 | A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome. |
Q35078628 | A novel rapid (20-minute) IL-6 release assay using blood mononuclear cells of patients with various clinical forms of drug induced skin injuries |
Q40440817 | Airway eosinophil migration into lymph nodes in mice depends on leukotriene C4. |
Q34052231 | Allergen-induced airway remodeling is impaired in galectin-3-deficient mice |
Q35864846 | Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma |
Q89978064 | Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA |
Q35913057 | CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules |
Q87438379 | CD63 is tightly associated with intracellular, secretory events chaperoning piecemeal degranulation and compound exocytosis in human eosinophils |
Q42500332 | Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection. |
Q36169557 | Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils. |
Q47119032 | Correlation of cutaneous sensitivity and cytokine response in children with asthma. |
Q36811319 | Cyclophilin D regulates necrosis, but not apoptosis, of murine eosinophils |
Q41044958 | Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders |
Q33669090 | Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules |
Q34225936 | Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins |
Q37989819 | Diagnostics and new developments in the treatment of ocular allergies |
Q98779284 | Elevated Levels of Activated and Pathogenic Eosinophils Characterize Moderate-Severe House Dust Mite Allergic Rhinitis |
Q64228933 | Emerging Roles for Immune Cells and MicroRNAs in Modulating the Response to Cardiac Injury |
Q33806763 | Endothelial and leukocyte heparan sulfates regulate the development of allergen-induced airway remodeling in a mouse model |
Q36091297 | Eosinophil crystalloid granules: structure, function, and beyond |
Q34479428 | Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity |
Q34406828 | Eosinophil secretion of granule-derived cytokines. |
Q41743992 | Eosinophil-derived IL-10 supports chronic nematode infection. |
Q38076473 | Eosinophil-derived cytokines in health and disease: unraveling novel mechanisms of selective secretion |
Q64961738 | Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity. |
Q39885996 | Eosinophilic inflammation in allergic asthma. |
Q87407558 | Eosinophilic pneumonias |
Q92708716 | Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii |
Q30399806 | Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus |
Q36053010 | Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis |
Q30275780 | Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease |
Q37672261 | Eosinophils and Th2 immunity: contemporary insights |
Q33756427 | Eosinophils and allergic airway disease: there is more to the story |
Q36607847 | Eosinophils and disease pathogenesis |
Q36105237 | Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge |
Q37743621 | Eosinophils in health and disease: the LIAR hypothesis |
Q36921021 | Eosinophils in innate immunity: an evolving story |
Q36847447 | Eosinophils in vasculitis: characteristics and roles in pathogenesis |
Q36032465 | Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation |
Q37692760 | Eosinophils regulate peripheral B cell numbers in both mice and humans |
Q35170969 | Eosinophils: changing perspectives in health and disease |
Q34769419 | Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity? |
Q35146265 | Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder |
Q39366933 | Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5. |
Q36032895 | Expression and subcellular localization of the Qa-SNARE syntaxin17 in human eosinophils. |
Q37369213 | Extracellular Microvesicle Production by Human Eosinophils Activated by "Inflammatory" Stimuli. |
Q30300955 | Factors driving the aspirin exacerbated respiratory disease phenotype |
Q38669187 | From neutrophils to macrophages: differences in regional adipose tissue depots |
Q38153632 | Functional extracellular eosinophil granules: a bomb caught in a trap |
Q37457196 | Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology |
Q40054108 | Functions of tissue-resident eosinophils |
Q46506319 | Gestational diabetes is associated with changes in placental microbiota and microbiome |
Q37165737 | Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF. |
Q37152231 | Human eosinophils modulate peripheral blood mononuclear cell response to Schistosoma mansoni adult worm antigen in vitro |
Q39464920 | Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytes |
Q34641855 | Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". |
Q39078255 | Hypoxia causes IL-8 secretion, Charcot Leyden crystal formation, and suppression of corticosteroid-induced apoptosis in human eosinophils. |
Q40219134 | ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s |
Q50292843 | IL12B:IL23A translocates from ER lumen to extracellular space |
Q34356793 | Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge. |
Q30300966 | Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes |
Q50984378 | Immunization induces activation of bone marrow eosinophils required for plasma cell survival. |
Q57028409 | Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways |
Q36980186 | Inhibition of inflammatory reactions in 2,4-Dinitrochlorobenzene induced Nc/Nga atopic dermatitis mice by non-thermal plasma |
Q35220479 | Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study |
Q24629279 | Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor |
Q28260328 | Multifaceted roles of cysteinyl leukotrienes in eliciting eosinophil granule protein secretion |
Q36763565 | Novel targeted therapies for eosinophilic disorders |
Q27003331 | Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field |
Q37779176 | Pathways for cytokine secretion. |
Q36188927 | Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses |
Q33563398 | Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine |
Q24610994 | Practical approach to the patient with hypereosinophilia |
Q30410446 | Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease |
Q58371266 | Schistosome infection is associated with enhanced whole-blood IL-10 secretion in response to cercarial excretory/secretory products |
Q40573007 | SiglecF+Gr1hi eosinophils are a distinct subpopulation within the lungs of allergen-challenged mice |
Q90430010 | Single-Cell Analyses of Human Eosinophils at High Resolution to Understand Compartmentalization and Vesicular Trafficking of Interferon-Gamma |
Q33534442 | Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model |
Q37184108 | Subcellular fractionation of human eosinophils: isolation of functional specific granules on isoosmotic density gradients |
Q38201782 | Surfactant protein SP-D modulates activity of immune cells: proteomic profiling of its interaction with eosinophilic cells. |
Q34167244 | Th1/Th2 cytokine pattern in Arab children with severe asthma. |
Q40843736 | Th2 Cytokine Levels Distort the Association of IL-10 and IFN-γ with Allergic Phenotypes |
Q64253660 | The Dynamics of the Skin's Immune System |
Q42146798 | The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands |
Q38990422 | The Regulatory Function of Eosinophils |
Q90455736 | The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease |
Q90706788 | The Role of Innate Leukocytes during Influenza Virus Infection |
Q28083968 | The differential expression of IL-4 and IL-13 and its impact on type-2 immunity |
Q34641880 | The expanding role(s) of eosinophils in health and disease |
Q86532774 | Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model |
Q34620159 | Updates in the treatment of ocular allergies |
Q57143105 | Vesicle-associated membrane protein 7-mediated eosinophil degranulation promotes allergic airway inflammation in mice |
Q37976619 | When FESS fails: the inflammatory load hypothesis in refractory chronic rhinosinusitis |
Search more.